Amiodarone and implantable cardioverter-defibrillators in congestive heart failure.
Sudden death accounts for a significant proportion of all death in patients with heart failure. Of currently available therapy, amiodarone and the implantable defibrillator (ICD) appear to have the greatest potential to reduce sudden death in heart failure. In this paper, the currently available information on the relative role of amiodarone and implantable defibrillators (ICD) in heart failure is reviewed.
Universitätsklinik Münster, Medizinische Klinik C, D-48129 Münster, Germany, Email: bockerd@uni-muenster.de, Germany.
D
D
Böcker
Universitätsklinik Münster, Medizinische Klinik C, D-48129 Münster, Germany, Email: bockerd@uni-muenster.de, Germany.
M
M
Block
Universitätsklinik Münster, Medizinische Klinik C, D-48129 Münster, Germany, Email: bockerd@uni-muenster.de, Germany.
W
W
Haverkamp
Universitätsklinik Münster, Medizinische Klinik C, D-48129 Münster, Germany, Email: bockerd@uni-muenster.de, Germany.
G
G
Breithardt
Key words Arrhythmia – amiodarone – defibrillator – antiarrhythmic drug therapy – electrical therapy